Donald Trump Softens Stance On Drug Prices, Sends Biotech Stocks Soaring

Donald Trump campaigned on reining in sky-high drug prices, and as recently as January, he said the industry was "getting away with murder." His tough talk has been bad news for biopharma stocks. However, an executive order that he could soon sign is reportedly friendlier to the industry than was expected. Is it time to buy biotech again?

Back to news